A simple method to determine phase preference of proteins on live cell membranes
Scientists at National University of Singapore have demonstrated a simple and fast method to determine if a biomolecule partitions into lipid domains on live cell membranes. was published in the Journal of Lipid Research.
Cellular membranes are dynamic assemblies of lipids and proteins with some components organized as domains. Proper cell function requires the partitioning of lipids and proteins into these domains, which are often rich in cholesterol and sphingolipids. However, they are too small (10-200 nm in size) and dynamic (possibly only tens of milliseconds in lifetime) to be observed even with modern super-resolution microscopy techniques.
Traditional methods to determine domain localization involve biochemical assays that require many cells, are prone to artifacts as they are conducted in vitro, and are slow. Although fluorescence-based techniques can probe these domains in live cells, they require specialized instrumentation and are often difficult to interpret.
The research team at NUS developed a simple fluidizer-based method to determine if a molecule prefers to partition into lipid domains on cell membranes.
The team added heptanol to live cells and showed that within 15 minutes it induces clustering of the nanometer-size lipid domains into larger micrometer-size domains that are easily detectable by standard fluorescence microscopes. The method works with both molecules that are genetically labelled with fluorescent proteins and those labelled using extrinsic labels, for example, antibodies.
The work was conducted in the lab of and led by first author , who is now a research fellow at Harvard Medical School and Boston Children's Hospital.
Gupta explained the significance of studying phase preference of molecules in membranes.
"Phase preference of molecules in membranes is fundamentally crucial for the essential biological processes originating at membranes, such as T-cell activation, a critical step during an immune response," she said. "Knowledge of the phase preference of molecules will support therapeutic development based on the modulation of lipid domains."
Wohland said: “The phase preference of molecules used to be difficult and time-consuming to establish. This new method, detected by chance, provides results in at most 15 minutes on live cells and can essentially be seen by eye in a simple microscope.”
The team hopes that this technique will enable a quick and facile identification of domain localization and will aid the wider research community.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.